Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07311889) titled 'Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD Use' on Dec. 16, 2025.
Study Type: Observational
Primary Sponsor: Elixir MD Inc
Condition:
Postoperative Pain
Postoperative Edema
Postoperative Ecchymosis
Surgical Wound Healing
Postsurgical Recovery
Intervention:
Other: Perioperative photobiomodulation light therapy
Recruitment Status: Not recruiting
Date of First Enrollment: January 1, 2026
Target Sample Size: 300
To know more, visit https://clinicaltrials.gov/study/NCT07311889
Disclaimer: Curated by HT Syndication....